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OBJECTIVE—To determine the prevalence of metabolic syndrome and to deﬁne optimal
ethnic-speciﬁc waist-circumference cutoff points in a rural South African black community.
RESEARCH DESIGN AND METHODS—This was a cross-sectional survey conducted
by random-cluster sampling of adults aged .15 years. Participants had demographic, anthro-
pometric, and biochemical measurements taken, including a 75-g oral glucose tolerance test.
Metabolic syndrome was deﬁned using the 2009 Joint Interim Statement (JIS) deﬁnition.
RESULTS—Of 947 subjects (758 women) studied, the age-adjusted prevalence of metabolic
syndrome was 22.1%, with a higher prevalence in women (25.0%) than in men (10.5%). Peak
prevalence was in the oldest age-group ($65 years) in women (44.2%) and in the 45- to 54-year
age-group in men (25.0%). The optimal waist circumference cutoff point to predict the presence
of at least two other components of the metabolic syndrome was 86 cm for men and 92 cm for
women.The crudeprevalenceof metabolic syndromewashigherwith theJIS deﬁnition (26.5%)
than with the International Diabetes Federation (IDF) (23.3%) or the modiﬁed Third Report of
the National Cholesterol Education Program Adult Treatment Panel (ATPIII) (18.5%) criteria;
there was very good agreement with the IDF deﬁnition (k = 0.90 [95% CI 0.87–0.94]) and good
concordance with ATPIII criteria (0.77 [0.72–0.82]).
CONCLUSIONS—There is a high prevalence of metabolic syndrome, especially in women,
suggestingthatthiscommunity,unlikeotherruralcommunitiesinAfrica,alreadyhasenteredthe
epidemic of metabolic syndrome. Waist circumference cutoff points differ from those currently
recommended for Africans.
Diabetes Care 34:1032–1037, 2011
M




ing factor (1–8). Metabolic syndrome is
common and is increasing in prevalence
worldwide, largely attributed to increas-
ing obesity and sedentary lifestyles, and
now is both a public health and clinical
problem (5).
Since the ﬁrst formalized deﬁnition
(6) of metabolic syndrome, there have
been several deﬁnitions using different
criteria (1–4,7,8), leading to widely
differing prevalence estimates (5). The
two major sets of criteria that have been
used arethose ofthe NationalCholesterol
Education Program Third Adult Treat-
ment Panel (ATPIII) (2–4) and Interna-
tional Diabetes Federation (IDF) (1).
The main difference between the two sys-
tems is that central obesity, as measured
by waist circumference, is a prerequisite
in the IDF deﬁnition, with cut points of
waist circumference being ethnic speciﬁc
and lower than in the ATPIII deﬁnition.
In 2009, an additional deﬁnition of
metabolic syndrome was proposed as a
joint interim statement (JIS) by several
organizations in an attempt to harmonize
the deﬁnition of metabolic syndrome (5).
The available information based on ATPIII
and IDF criteria suggests that metabolic
syndrome is pandemic but that prevalence
varies widely depending on the ethnic
groups studied and criteria applied (9).
Sub-Saharan Africa currently is ex-
periencing one of the most rapid demo-
graphic and epidemiological transitions
withoneofthefastestratesofurbanization,
which is thought to be mainly responsible
for the rising burden of diabetes and other
noncommunicable diseases (10–13).
The available information on the
prevalence of metabolic syndrome in
epidemiology studies in sub-Saharan Af-
rica is limited to reports on West Africans
in Cameroon (14), Benin (15), and Ni-
geria (16) and based on ATPIII (2–4) or
IDF deﬁnitions (1). The crude prevalence
inthesestudiesrangedfromanabsenceor
low prevalence (0–4.1%) in rural com-
munities in all three countries as well as
in an urban community in Cameroon. In
Benin,prevalence was higher insemiurban
(6.4%) and urban samples (11.0%). To
date,therearenoreportsontheprevalence
of metabolic syndrome from epidemiology
studies in South Africa and none (urban or
rural) using the JIS deﬁnition.
A cross-sectional diabetes epidemiol-
ogy study in rural South Africans of Zulu
descent allowed for the determination of
the prevalence of metabolic syndrome
using the JIS deﬁnition and the optimal
waist circumference cutoff points to pre-
dict the presence of metabolic syndrome
in this population.
RESEARCH DESIGN AND
METHODS—A detailed description of
the survey design and procedures has
been previously published (17).
Survey design
Inbrief,thiswasacross-sectionalstudyof
nonpregnant individuals aged .15 years,
selected by random-cluster sampling, un-
dertaken over a 3-month period in a rural
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ORIGINAL ARTICLEAfrican (black) community of Zulu de-
scent in the Ubombo district of the prov-
ince of KwaZulu-Natal in South Africa.
Informed consent was obtained from
all participants, and the University of
KwaZulu-Natal Ethics Committee ap-
proved the study.
Survey procedure
The survey methodology was based on
the World Health Organization ﬁeld
guide for diabetes and noncommunicable
disease risk factor surveys (18). On the
test day, all consenting subjects provided
information for a questionnaire and un-
derwent an anthropometric examination
and a 75-g oral glucose tolerance test
(OGTT) with additional fasting blood
tests.
The anthropometric examination in-
cluded measurement of height, weight,
waist and hip circumference, and blood
pressure (18). BMI was used as a measure
oftotal-bodyobesityandwaistcircumfer-
ence and waist-to-hip ratio (WHR) as
measures of central (upper-body or ab-
dominal) obesity (19). Hypertension
was deﬁned as systolic blood pressure
$140mmHgand/ordiastolicbloodpres-
sure $90 mmHg.
Venous blood samples were drawn
after an overnight fast and 2 h after a 75-g
glucose load (OGTT) (6) for measure-
ment ofplasmaglucose and fasting serum
lipids and uric acid. Blood samples were
keptoniceandcentrifugedwithin6hand
were separated and stored at 230°C until
determination.
Biochemical methods
Plasma glucose was measured by a glu-
cose oxidase method, and serum total
cholesterol,HDLcholesterol,totaltriglyc-
erides, and uric acid was measured by an
enzymatic calorimetric method with kits
from Boehringer Mannheim (Mannheim,
Germany) and Diagnostica (monotest
cholesterol, cholesterol oxidase–phenol+
aminophenazone [CHOD-PAP]; perido-
chrome uric acid). LDL cholesterol was
calculated by the Freidewald formula. In-
terassay coefﬁcients of variation for the
biochemical assays used were as follows:
glucose 2.7–3.1%, cholesterol 1.6–2.4%,
triglycerides 1.5–3.0%, and uric acid
2.4–3.7%.
Metabolic syndrome deﬁnitions
Metabolic syndrome was deﬁned based
on the 2009 JIS deﬁnition (5) (i.e., de-
ﬁned by any three of the following ﬁve
components [risk factors]: central obesity
as elevated waist circumference [$94 cm
for male subjects and 80 cm for female
subjects]; elevated serum triglycerides
[$1.7 mmol/L]; reduced serum HDL
cholesterol [,1.0 mmol/L for male sub-
jectsand1.3mmol/Lforfemalesubjects];
elevated blood pressure [systolic blood
pressure $130 mmHg and/or diastolic
blood pressure $85 mmHg]; and ele-
vated fasting blood glucose [$5.6
mmol/L]). IDF Europid cut points (1)
were used for elevated waist circumfer-
ence, as recommended for sub-Saharan
Africa populations (5). The JIS deﬁnition
was used to determine the prevalence of
metabolic syndrome and its individual
components. For comparison with other




Statistical analysis was performed using
SPSS (version 15; SPSS, Chicago, IL).
Numerical variables are expressed as
means 6 SD. In bivariate analysis, the
Student t test was used. The x
2 test was
used for categorical variables. A test was
considered signiﬁcant if P , 0.05.
For prevalence estimates, the JIS, IDF,
andATPIIIcriteriawereappliedtosubjects
who had all ﬁve components of the met-
abolic syndrome measured. Additional in-
tergroup analyses were undertaken using
theJIScriteria.Theage-standardizedprev-
alencerateswerecalculatedwiththedirect
method, using the world population as a
standard (20).
The receiver operating characteristic
(ROC) curve for waist circumference to
predict the presence of at least two other
components of the metabolic syndrome,
as deﬁned by JIS criteria, was plotted.
The optimal cutoff values of waist cir-
cumferencewerecalculatedbyplottingthe
true-positive rate (sensitivity) against the
false-positive rate (1-speciﬁcity). To assess
the level of concordance (agreement) be-
tween the JIS and IDF or ATPIII deﬁni-
tions, the k statistic was calculated (21).
RESULTS
Response rate and study group
Of 1,300 subjects selected, 1,025 (210
male and 815 female) participated, with
an overall response rate of 78.9% (17).
Thestudygroupforthisanalysisincluded
947 subjects (189 male and 758 female)
who had data on all components of the
metabolic syndrome.
Total study group
Table 1 shows the characteristics of
the total (n = 947) study group by sex.
The mean age was 46.5 6 18.1 years.
Mean BMI, waist and hip circumference,
WHR, and the prevalence of total-body
and central adiposity were higher in
women.
Fewer women than men reported a
history of any urban living (20.8 vs.
39.7%; P , 0.001) and in the proportion
of life spent in an urban area (4.2 vs.
9.5%; P , 0.001). The majority of men
(61.9%) and women (79.5%) either were
pensioners (men 21.7% vs. women
25.1%; P , 0.001), engaged in home
duties(men24.9%vs.women40.0%;P,
0.001), scholars (men 15.9% vs. women
7.4%; P , 0.001), or unemployed (men
15.3% vs. women 14.4%; P , 0.001).
Only 22.1% of men and 13.1% of women
were employed. The occupational history
(men vs. women) was as follows: manual
laborer (13.2 vs. 6.3%; P , 0.001); skilled
worker (7.9 vs. 6.3%; P , 0.001); and of-
ﬁce worker (1.1 vs. 0.5%; P , 0.001). The
average monthly income (South African
Rand [ZAR]) per household (men vs.
women) was low (620.5 6 757.4 ZAR
vs. 543.5 6 578.9 ZAR; P =0 . 1 ) ,w i t h
many family members (n = 8.9 6 5.0 vs.
8.0 6 4.2; P = 0.02) being supported per
household.
Prevalence
Metabolic syndrome. Table 2 shows the
prevalenceofmetabolicsyndrome bysex.
Using JIS criteria, the crude overall prev-
alenceofmetabolicsyndromewas26.5%,
with a higher prevalence in women
(30.2%) than in men (11.6%). Using
age-speciﬁc rates, the prevalence of met-
abolic syndrome increased with age in
both men and women; peak prevalence
was in the 45- to 54-year age-group in
men (25.0%) and in the oldest age-group
($65 years) in women (44.2%). The age-
adjusted prevalence was lower at 22.1%
for the total study group, 10.5% for men,
and 25.0% for women. In the total study
group, the prevalence (crude/adjusted)
was lower with both IDF (23.3/19.2%)
and ATP III (18.5/15.0%) criteria. This
also was true when the sexes were exam-
ined separately (Table 2).
Individual components. The prevalence
of the individual components of meta-
bolic syndrome is shown in Table 3. The
most frequent individual component was
low serum HDL cholesterol in women
(65.2%) and elevated blood pressure in
men(47.1%);theleastfrequentcomponent
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cose (FPG) (10.6%) and in men was both
elevated FPG (13.8%) and elevated serum
total triglycerides (13.8%).
In subjects with metabolic syndrome,
the most frequent individual component
was a high waist circumference in both
men (90.9%) and women (96.9%); the
least frequent component was elevated
FPGinmen(50.0%)andwomen(27.1%)
and low serum HDL cholesterol in men
(50.0%). As expected, there was a signif-
icant difference between those with met-
abolic syndrome and those without for
each of the individual components.
Optimal waist circumference cutoff
points
The optimal cut points of waist circum-
ference for predicting at least two other
components of the metabolic syndrome,
as deﬁned by the JIS criteria, was 86 cm
for men (sensitivity 61.2%, speciﬁcity
82.9%) and 92 cm for women (sensitivity
45.9%, speciﬁcity 81.9%) (Fig. 1).
Comparison and agreement between
the JIS and IDF or ATPIII deﬁnitions
Comparison between the JIS and IDF
deﬁnitions showed that the crude overall
prevalence was higher with the JIS crite-
ria (26.5%; n =2 5 1 )t h a nw i t ht h eI D F
criteria(23.3%;n=221);23.0%(n=218)
had metabolic syndrome using both sets
of deﬁnitions. The agreement between
the two systems was very good in the total
studygroup(k=0.90[95%CI0.87–0.93])
as well as in men (k =0 . 9 5[ 0 . 8 8 –1.02])
and women (k =0 . 8 9[ 0 . 8 5 –0.93]) sep-
arately.
Thecrudeoverallprevalencealsowas
higher when compared with the ATPIII
criteria (18.5%; n = 175); the current sys-
tem picked up all 175 subjects deﬁned by
the ATPIII criteria. The concordance be-
tween the two systems was good in the
total study group (k = 0.77 [95% CI
0.72–0.82]) and in women (k =0 . 7 6
[0.70–0.81]) and very good in men (k =
0.86 [0.73–0.98]).
CONCLUSIONS—This study in a ru-
ral South African community of Zulu
descent and using the 2009 JIS deﬁnition
has highlighted a high prevalence of met-
abolicsyndrome,especiallyinwomen.The
most frequent individual component in
subjects with metabolic syndrome was a
high waist circumference. Optimal waist
circumference cut points also have been
identiﬁed.
To our knowledge, this is the ﬁrst re-
port on the prevalence of metabolic syn-
drome insub-SaharanAfrica using theJIS
deﬁnition. Available evidence on the im-
pact of metabolic syndrome from epide-
miology studies in sub-Saharan Africa is
limited to those using IDF (1) or ATPIII
(2–4)criteriainWestAfricansinCameroon
(14),Benin(15),andNigeria(16)andwith
only crude prevalence rates reported.
Using ATPIII criteria, the prevalence
of metabolic syndrome in this study
(crude 18.5%) is higher than in rural
communities in Cameroon (0.0%) or
Nigeria (all 3.0%; men 2.1% and women
2.7%). Based on the IDF criteria, the
prevalence is higher in this study (crude
23.3%) than in rural Cameroon (men
0.0% and women 0.3%) or Benin (all
4.1%; men 0.0% and women 8.2%) and
even when compared with urban com-
munities in Cameroon (men 1.2% and
women 1.5%) and Benin (all 11.0%; men
5.0% and women 17.0%).
When compared with other regions
of the world, and using IDF and ATPIII
criteria, the prevalence in women in this
study is higher than in Asian groups from
Japan, China, Mauritius, and India and
some European communities but lower
thaninethnicgroupsintheUnitedStates,
including in African Americans (9).
The higher prevalence of metabolic
syndrome in women in this study com-
pared with other rural sub-Saharan Africa
communitiesislikelyrelatedtothehigher
prevalenceofobesity and theroleofother
factors, namely that physical activity and
dietary factors needs to be established.
Previous reports (10,12,22) have con-
ﬁrmed the high prevalence of obesity in
South Africans. In this study, 47.3% of
women were overweight or obese. Al-
though this rate is lower than the national
prevalence (56.6%) (22), it is higher than
in rural communities in Cameroon (9.5%)
and Nigeria (4.2%) and similar to rates
in urban female subjects in Cameroon
(47.0%) (16,23). The proportion of those
who were obesein this study (22.6%) also
is lower than the national estimate
(31.8%) or in semiurban (40.2%) and ur-
ban (43.9%) South African women but
higher than in rural Nigerians (2.4%)
and rural (0.7%) or urban (10.0%)
Cameroonians (16,22,23).
The most frequent individual com-
ponentwaslowserumHDLcholesterolin
women and elevated blood pressure in
men. Similar ﬁndings have been reported
Table 1—Characteristics of the study group (n = 947) by sex
Men Women P
n (%) 189 (20) 758 (80)
Age (years) 46.4 6 20.6 46.6 6 18.2 0.9
BMI (kg/m
2) 22.8 6 6.9 26.0 6 6.5 ,0.001
Waist (cm) 83.1 6 12.1 86.0 6 13.4 0.004
Hip (cm) 95.8 6 11.1 102.0 6 13.5 ,0.001
WHR 0.87 6 0.07 0.84 6 0.07 ,0.001
Systolic blood pressure (mmHg) 128.2 6 16.7 126.5 6 29.9 0.5
Diastolic blood pressure (mmHg) 80.5 6 10.6 80.3 6 18.7 0.8
BMI (kg/m
2)( % )
$25 to ,30 13.2 24.7 ,0.001
$30 8.5 22.6 ,0.001
Waist (cm) (men/women) (%)
$94/80 18.5 63.3 ,0.001
$102/88 8.5 39.0 ,0.001
WHR .1.0 men/0.85 women (%) 2.1 45.8 ,0.001
Hypertension (%) 30.7 24.7 0.1
Plasma glucose (mmol/L)
0-min 4.9 6 2.1 4.9 6 1.4 0.7
120-min 6.1 6 2.3 6.2 6 2.5 0.7
Serum lipids (mmol/L)
Total cholesterol 4.0 6 1.0 4.1 6 1.1 0.2
Total triglycerides 1.1 6 0.7 1.0 6 0.7 0.6
HDL cholesterol 1.24 6 0.44 1.24 6 0.38 0.5
LDL cholesterol 2.2 6 1.0 2.4 6 0.9 0.006
Serum uric acid (mmol/L) 0.31 6 0.08 0.26 6 0.07 ,0.001
Data are means 6 SD, unless otherwise indicated. P values are for comparison between men and women.
1034 DIABETES CARE, VOLUME 34, APRIL 2011 care.diabetesjournals.org
Metabolic syndrome and rural South Africansinrural Nigerians (16), whereas elevated
blood pressure alone was the most fre-
quent component in men in rural and
urban Cameroon and semiurban Benin
(14,15). Both these variables are known
risk factors for CVD (5); these ﬁndings
maysuggestthatifthecurrenttrendcon-
tinues, this population is at increased
risk for coronary artery disease. To
date, the major type of CVD in Africans
iscerebrovasculardisease,withcoronary
arterydiseasebeinguncommon(12).On
the other hand, it may suggest an ethnic
predisposition to this type of dyslipide-
mia, as has been suggested for Iranians
(24). The least common individual
component was a high FPG (in men
and women) and elevated serum triglyc-
erides (in men). A consistent ﬁnding in
all the African studies, except in South
African women, was that the least fre-
quent component was elevated serum
triglycerides. Whether this contributes
to the low risk of coronary artery disease
in this population is unclear and would
require additional studies to establish its
signiﬁcance.
In subjects with metabolic syndrome,
the most frequent component was a high
waist circumference. In a previous report
(17), waist circumference was found to
be a risk factor associated with diabetes
in this population; the impact of this vari-
able on future CVD in Africans needs to
be established.
There was very good agreement be-
tween the JIS and IDF deﬁnitions. This is
not surprising given that the components
are the same in both sets; elevated waist
circumference was found in .90% of
subjects with metabolic syndrome in
this study, and the cut points for waist
circumference are the same.
To our knowledge, this is the ﬁrst
report in Africans that attempts to deﬁne
waist circumference cut points to predict
metabolic syndrome. The cut point for
women (92 cm) is higher than currently
recommended for Africans (i.e., IDF Eu-
ropid cut points of 80 cm) (1,5) but sim-
ilar to those recently reported in Iranians
(24). On the other hand, the cut point in
men (86.3 cm) is lower than currently re-
commended but similar to that reported
in Japanese subjects (25). Additional stud-
ies are required in other African communi-
ties to conﬁrm this ﬁnding.
Themajorlimitationsofthisstudyare
the cross-sectional design and the over-
representation of women; the latter is
accountedforbythemigrantlaborsystem
in our country, with men in the econom-
ically productive age-group moving to
urban areas, whereas women, children,
and older individuals remain in the rural
areas (17).
In summary, this study shows a high
prevalence of metabolic syndrome, espe-
cially in women, and suggests that this
community, unlike other rural commu-
nities in Africa, already has entered the
global pandemic. It conﬁrms the need for
implementing national policies for its
prevention and control in this and other
sub-Saharan African countries that face a
rising burden of diabetes and CVD over
the next 2 decades. Waist circumference
cutoff points for both men and women
Table 2—Age- and sex-speciﬁc and age-adjusted prevalence of metabolic syndrome




Men (n = 189)
15–24 44 0.0 (0) 0.0 (0) 0.0 (0)
25–34 20 5.0 (1) 10.0 (2) 5.0 (1)
35–44 22 13.6 (3) 13.6 (3) 4.5 (1)
45–54 28 25.0 (7) 25.0 (7) 21.4 (6)
55–64 31 12.9 (4) 12.9 (4) 12.9 (4)
$65 44 15.9 (7) 13.6 (6) 11.4 (5)
Total crude 189 11.6 (22) 11.6 (22) 9.0 (17)
Age adjusted — 10.5 11.2 7.9
Women (n =7 5 8 )
15–24 101 5.9 (6) 4.0 (4) 4.0 (4)
25–34 123 16.3 (20) 12.2 (15) 6.5 (8)
35–44 149 26.2 (39) 22.8 (34) 17.4 (26)
45–54 106 39.6 (42) 33.0 (35) 28.3 (30)
55–64 124 42.7 (53) 39.5 (49) 29.8 (37)
$65 154 44.2 (68) 39.6 (61) 34.4 (53)
M i s s i n g 1 0( 1 ) 0( 1 ) 0( 1 )
Total crude 758 30.2 (229) 26.3 (199) 20.9 (158)
Age adjusted — 25.0 21.2 16.8
Data are % (n).
Table 3—Prevalence (%) of the individual components of metabolic syndrome based







n 189 167 22
High waist circumference 16.4 6.6 90.9 ,0.001
High triglycerides 13.8 7.8 59.1 ,0.001
Low HDL cholesterol 29.1 26.3 50.0 0.02
High blood pressure 47.1 42.5 81.8 0.001
High FPG 13.8 9.0 50.0 ,0.001
Women
n 758 529 229
High waist circumference 62.4 47.4 96.9 ,0.001
High triglycerides 11.7 2.1 34.1 ,0.001
Low HDL cholesterol 65.2 54.3 90.4 ,0.001
High blood pressure 48.4 30.6 89.5 ,0.001
High FPG 10.6 3.4 27.1 ,0.001
Data are percentages, unless otherwise indicated. *Waist circumference $94/80 cm (for men/women),
serum triglycerides $1.7 mmol/L, serum HDL cholesterol ,1.0/1.3 mmol/L (for men/women), systolic
$130 mmHg and/or diastolic blood pressure $85 mmHg, FPG $5.6 mmol/L.
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